Drug therapy: Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice

被引:701
作者
Riggs, BL
Hartmann, LC
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol & Metab, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA
关键词
D O I
10.1056/NEJMra022219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:618 / 629
页数:12
相关论文
共 105 条
  • [1] Tamoxifen: Five versus ten years - Is the end in sight?
    Abrams, JA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) : 662 - 664
  • [2] *ATLAS TRIAL, 2003, NIH CLIN TRIAL
  • [3] Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
    Barrett-Connor, E
    Grady, D
    Sashegyi, A
    Anderson, PW
    Cox, DA
    Hoszowski, K
    Rautaharju, P
    Harper, KD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07): : 847 - 857
  • [4] Hormones and heart disease in women: Heart and estrogen progestin replacement study in perspective
    Barrett-Connor, E
    Stuenkel, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) : 1848 - 1853
  • [5] Baum M, 2002, LANCET, V359, P2131
  • [6] Raloxifene and estrogen reduces progression of advanced atherosclerosis - a study in ovariectomized, cholesterol-fed rabbits
    Bjarnason, NH
    Haarbo, J
    Byrjalsen, I
    Alexandersen, P
    Kauffman, RF
    Christiansen, C
    [J]. ATHEROSCLEROSIS, 2001, 154 (01) : 97 - 102
  • [7] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study
    Bonneterre, J
    Thürlimann, B
    Robertson, JFR
    Krzakowski, M
    Mauriac, L
    Koralewski, P
    Vergote, I
    Webster, A
    Steinberg, M
    von Euler, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3748 - 3757
  • [8] Estrogen receptors α and β are differentially expressed in developing human bone
    Bord, S
    Horner, A
    Beavan, S
    Compston, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) : 2309 - 2314
  • [9] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [10] Buzdar AU, 1998, CLIN CANCER RES, V4, P527